International Neurourology Journal

Korean Continence Society (대한배뇨장애요실금학회)
권호 표지
DOI QR코드

DOI QR Code

Long-term Outcomes of Augmentation Cystoplasty in a Pediatric Population With Refractory Bladder Dysfunction: A 12-Year Follow-up Experience at Single Center

  • Received : 2018.07.12
  • Accepted : 2018.09.18
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Purpose: Augmentation cystoplasty (AC) is a surgical procedure used in adults and children with refractory bladder dysfunction, including a small bladder capacity and inadequate bladder compliance, and in whom conservative and medical treatment has failed. This study was aimed to determine the long-term outcomes of AC in children. Methods: A retrospective analysis was conducted of 42 patients (31 males; mean age, $14.2{\pm}6.2years$) who underwent AC for neurogenic and nonneurogenic bladder dysfunction, with a median $12.0{\pm}1.5years$ of follow-up. All patients underwent AC using the ileum with or without continent reconstruction. Pre-AC, concurrent, and post-AC procedures and complications were analyzed. Patients who underwent ureterocystoplasty, were lost to follow-up, or had less than 10 years of follow-up were excluded. The primary outcomes were the complication and continence rates, the post-AC linear rate of height and weight gain, and renal function. The Student t-test was used to evaluate between-group differences and the paired t-test was used to evaluate longitudinal changes in measured variables. Results: Renal function was stable or improved in 32 of 42 patients (76.2%), with a post-AC continence rate of 88.1%. Thirty patients (71.4%) required 72 procedures post-AC. There was no statistically significant difference in the mean percentile of height (P=0. 212) or weight (P=0.142) of patients in the pre- and post-AC periods. No cases of bladder perforation or malignancy were detected. Conclusions: We consider AC to be a safe and effective procedure that does not negatively affect future physical growth, while achieving a good rate of stable renal function. Patients need long-term follow-up to address long-term complications.

Keywords

References

  1. Adams MC, Joseph DB. Urinary tract reconstruction in children. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 3656-702.
  2. Keenan A, Whittam B, Misseri R, Cain M. Long-term outcomes following bladder augmentation in children with neurogenic bladder. Curr Bladder Dysfunct Rep 2014;9:275-81. https://doi.org/10.1007/s11884-014-0268-1
  3. Surer I, Ferrer FA, Baker LA, Gearhart JP. Continent urinary diversion and the exstrophy-epispadias complex. J Urol 2003;169:1102-5. https://doi.org/10.1097/01.ju.0000044921.19074.d0
  4. Scales CD Jr, Wiener JS. Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature. J Urol 2008;180:2323-9. https://doi.org/10.1016/j.juro.2008.08.050
  5. Hayashi Y, Yamataka A, Kaneyama K, Kato Y, Lane GJ, Miyano T. Review of 86 patients with myelodysplasia and neurogenic bladder who underwent sigmoidocolocystoplasty and were followed more than 10 years. J Urol 2006;176(4 Pt 2):1806-9. https://doi.org/10.1016/j.juro.2006.03.123
  6. Austin JC. Long-term risks of bladder augmentation in pediatric patients. Curr Opin Urol 2008;18:408-12. https://doi.org/10.1097/MOU.0b013e328300587c
  7. Husmann DA, Rathbun SR. Long-term follow up of enteric bladder augmentations: the risk for malignancy. J Pediatr Urol 2008;4:381-5. https://doi.org/10.1016/j.jpurol.2008.06.003
  8. Schaefer M, Kaiser A, Stehr M, Beyer HJ. Bladder augmentation with small intestinal submucosa leads to unsatisfactory long-term results. J Pediatr Urol 2013;9(6 Pt A):878-83. https://doi.org/10.1016/j.jpurol.2012.12.001
  9. Feng AH, Kaar S, Elder JS. Influence of enterocystoplasty on linear growth in children with exstrophy. J Urol 2002;167:2552-5. https://doi.org/10.1016/S0022-5347(05)65035-5
  10. Gros DA, Dodson JL, Lopatin UA, Gearhart JP, Silver RI, Docimo SG. Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy. J Urol 2000;164(3 Pt 2):917-20. https://doi.org/10.1016/S0022-5347(05)67217-5
  11. Ragavan M, Tandon N, Bhatnagar V. Exstrophy bladder: effect of sigmoid colocystoplasty on physical growth and bone mineral density. J Indian Assoc Pediatr Surg 2011;16:45-9. https://doi.org/10.4103/0971-9261.78129
  12. Gerharz EW, Preece M, Duffy PG, Ransley PG, Leaver R, Woodhouse CR. Enterocystoplasty in childhood: a second look at the effect on growth. BJU Int 2003; 91:79-83.
  13. Soergel TM, Cain MP, Misseri R, Gardner TA, Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol 2004;172(4 Pt 2):1649-51. https://doi.org/10.1097/01.ju.0000140194.87974.56
  14. Higuchi TT, Granberg CF, Fox JA, Husmann DA. Augmentation cystoplasty and risk of neoplasia: fact, fiction and controversy. J Urol 2010;184:2492-6. https://doi.org/10.1016/j.juro.2010.08.038
  15. Mundy AR, Stephenson TP. "Clam" ileocystoplasty for the treatment of refractory urge incontinence. Br J Urol 1985; 57:641-6 https://doi.org/10.1111/j.1464-410X.1985.tb07023.x
  16. Obermayr F, Szavay P, Schaefer J, Fuchs J. Outcome of augmentation cystoplasty and bladder substitution in a pediatric age group. Eur J Pediatr Surg 2011;21:116-9. https://doi.org/10.1055/s-0030-1267223
  17. Dykes EH, Duffy PG, Ransley PG. The use of the Mitrofanoff principle in achieving clean intermittent catheterisation and urinary continence in children. J Pediatr Surg 1991;26:535-8. https://doi.org/10.1016/0022-3468(91)90700-4
  18. Kari J, Al-Deek B, Elkhatib L, Salahudeen S, Mukhtar N, Al Ahmad R, et al. Is mitrofanoff a more socially accepted clean intermittent catheterization (CIC) route for children and their families? Eur J Pediatr Surg 2013;23:405-10.
  19. Fontaine E, Leaver R, Woodhouse CR. The effect of intestinal urinary reservoirs on renal function: a 10-year follow-up. BJU Int 2000;86:195-8. https://doi.org/10.1046/j.1464-410x.2000.00769.x
  20. Mehmood S, Seyam R, Firdous S, Altaweel WM. Factors predicting renal function outcome after augmentation cystoplasty. Int J Nephrol 2017;2017:3929352.
  21. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int 2012;109:1280-93. https://doi.org/10.1111/j.1464-410X.2011.10650.x
  22. DeFoor W, Minevich E, Reddy P, Sekhon D, Polsky E, Wacksman J, et el. Bladder calculi after augmentation cystoplasty: risk factors and prevention strategies. J Urol 2004;172(5 Pt 1):1964-6. https://doi.org/10.1097/01.ju.0000140911.43898.15
  23. Khoury AE, Salomon M, Doche R, Soboh F, Ackerley C, Jayanthi R, et al. Stone formation after augmentation cystoplasty: the role of intestinal mucus. J Urol 1997;158(3 Pt 2):1133-7. https://doi.org/10.1016/S0022-5347(01)64404-5
  24. Hensle TW, Bingham J, Lam J, Shabsigh A. Preventing reservoir calculi after augmentation cystoplasty and continent urinary diversion: the influence of an irrigation protocol. BJU Int 2004;93:585-7. https://doi.org/10.1111/j.1464-410X.2003.04664.x
  25. Szymanski KM, Misseri R, Whittam B, Lingeman JE, Amstutz S, Ring JD, et al. Bladder stones after bladder augmentation are not what they seem. J Pediatr Urol 2016;12:98.e1-6. https://doi.org/10.1016/j.jpurol.2015.06.021
  26. Abes M, Sarihan H, Madenci E. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation. J Pediatr Surg 2003;38:230-2. https://doi.org/10.1053/jpsu.2003.50050
  27. Mundy AR, Nurse DE. Calcium balance, growth and skeletal mineralisation in patients with cystoplasties. Br J Urol 1992;69:257-9. https://doi.org/10.1111/j.1464-410X.1992.tb15524.x
  28. Mingin GC, Nguyen HT, Mathias RS, Shepherd JA, Glidden D, Baskin LS. Growth and metabolic consequences of bladder augmentation in children with myelomeningocele and bladder exstrophy. Pediatrics 2002;110:1193-8. https://doi.org/10.1542/peds.110.6.1193
  29. Hafez AT, McLorie G, Gilday D, Laudenberg B, Upadhyay J, Bagli D, et al. Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. J Urol 2003;170(4 Pt 2):1639-41. https://doi.org/10.1097/01.ju.0000083887.58315.7e
  30. DeFoor W, Tackett L, Minevich E, Wacksman J, Sheldon C. Risk factors for spontaneous bladder perforation after augmentation cystoplasty. Urology 2003;62:737-41. https://doi.org/10.1016/S0090-4295(03)00678-2
  31. Metcalfe PD, Casale AJ, Kaefer MA, Misseri R, Dussinger AM, Meldrum KK, et al. Spontaneous bladder perforations: a report of 500 augmentations in children and analysis of risk. J Urol 2006;175:1466-70. https://doi.org/10.1016/S0022-5347(05)00672-5
  32. Austin JC, Elliott S, Cooper CS. Patients with spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival. J Urol 2007;178(3 Pt 1):798-801. https://doi.org/10.1016/j.juro.2007.05.055
  33. Drake MJ, Apostolidis A, Emmanuel A, Gajewski J, Harrison SC, Heesakkers J, et al. Neurologic urinary and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 5th ed. Paris: ICUD-EAU; 2013. p. 827-954.
  34. Lopez Pereira P, Moreno Valle JA, Espinosa L, Alonso Dorrego JM, Martinez Urrutia MJ, Lobato Romera R, et al. Are urodynamic studies really needed during bladder augmentation follow-up? J Pediatr Urol 2009;5:30-3. https://doi.org/10.1016/j.jpurol.2008.07.006

Cited by

  1. Bladder Augmentation (Enterocystoplasty): the Current State of a Historic Operation vol.20, pp.9, 2018, https://doi.org/10.1007/s11934-019-0919-z
  2. The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature review vol.39, pp.6, 2018, https://doi.org/10.1002/nau.24432